• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼患者的全身药物治疗。

Systemic medication usage in glaucoma patients.

机构信息

?>Department of Ophthalmology, Jewish General Hospital, McGill University, Montreal, Que; University of Manitoba, Winnipeg, Man.

Royal Victoria Hospital, Montreal, Que.

出版信息

Can J Ophthalmol. 2018 Jun;53(3):242-245. doi: 10.1016/j.jcjo.2017.10.029. Epub 2018 Feb 1.

DOI:10.1016/j.jcjo.2017.10.029
PMID:29784160
Abstract

OBJECTIVE

To study the prevalence of the systemic use of some common classes of medications by glaucoma patients and their relationship to the prevalence and severity of chronic open-angle glaucoma (COAG) and primary-angle closure glaucoma (PACG).

DESIGN

Observational prospective single-centre cross-sectional study.

METHODS

Glaucoma patients or their pharmacist provided an updated list of all systemic medications that they presently use. The relationship between glaucoma type and severity and medication use for diseases other than glaucoma was assessed by univariate statistics.

RESULTS

We studied 514 glaucoma patients. They use a mean of 4.9 oral medications prescribed by a mean of 2.1 doctors. Antihypertensives, medications with anticholinergic properties, steroids, anticoagulants, and thyroid hormones were the most frequently prescribed groups of medications, used by 251 (49%), 178 (35%), 100 (19%), 218 (42%), and 108 (21%) patients, respectively. Steroid usage was associated with advanced visual field loss in COAG patients. Antihypertensives and medications with anticholinergic properties were not associated with severity of COAG and PACG, respectively, and these 3 groups were not associated with an increased prevalence of diagnosis of COAG or PACG.

CONCLUSION

Glaucoma patients take many systemic medications in addition to their topical glaucoma treatment.

摘要

目的

研究青光眼患者全身使用某些常见类别的药物的流行情况及其与慢性开角型青光眼(COAG)和原发性闭角型青光眼(PACG)的流行和严重程度的关系。

设计

观察性前瞻性单中心横断面研究。

方法

青光眼患者或其药剂师提供了他们目前正在使用的所有全身药物的最新清单。通过单变量统计评估了青光眼类型和严重程度与治疗青光眼以外疾病的药物使用之间的关系。

结果

我们研究了 514 名青光眼患者。他们平均使用 4.9 种口服药物,平均由 2.1 位医生开具。抗高血压药、具有抗胆碱能特性的药物、类固醇、抗凝剂和甲状腺激素是最常开的药物组,分别有 251 名(49%)、178 名(35%)、100 名(19%)、218 名(42%)和 108 名(21%)患者使用。类固醇的使用与 COAG 患者的视野进行性丧失有关。抗高血压药和具有抗胆碱能特性的药物与 COAG 和 PACG 的严重程度分别无关,这 3 组与 COAG 或 PACG 的诊断率增加无关。

结论

除了局部治疗青光眼外,青光眼患者还会服用许多全身性药物。

相似文献

1
Systemic medication usage in glaucoma patients.青光眼患者的全身药物治疗。
Can J Ophthalmol. 2018 Jun;53(3):242-245. doi: 10.1016/j.jcjo.2017.10.029. Epub 2018 Feb 1.
2
Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma.多种青光眼药物对青光眼患者视觉功能和生活质量的影响
Can J Ophthalmol. 2001 Dec;36(7):385-90. doi: 10.1016/s0008-4182(01)80082-x.
3
A prospective longterm study of primary chronic angle closure glaucoma.原发性慢性闭角型青光眼的前瞻性长期研究。
Acta Ophthalmol Scand. 2004 Apr;82(2):209-13. doi: 10.1046/j.1600-0420.2004.00218.x.
4
Long-term evaluation of ocular hypertension with primary angle closure and primary open angles.原发性闭角型和原发性开角型青光眼高眼压症的长期评估
Int Ophthalmol. 2019 Apr;39(4):803-812. doi: 10.1007/s10792-018-0872-8. Epub 2018 Mar 5.
5
Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up.在两种术前药物治疗无法控制的开角型青光眼中植入两个第二代小梁微旁路支架并局部应用曲伏前列素:18个月随访
Clin Exp Ophthalmol. 2017 Nov;45(8):797-802. doi: 10.1111/ceo.12958. Epub 2017 Jun 2.
6
The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data.青光眼强化治疗研究(GITS),一项随机临床试验:设计、方法学和基线数据。
Acta Ophthalmol. 2018 Sep;96(6):557-566. doi: 10.1111/aos.13791. Epub 2018 Aug 31.
7
Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.瓶盖颜色对促进青光眼患者与医生就药物标识进行准确沟通的能力。
Ophthalmology. 2015 Dec;122(12):2373-9. doi: 10.1016/j.ophtha.2015.06.013. Epub 2015 Aug 8.
8
The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.低压性青光眼治疗研究(LoGTS):研究设计及入组患者的基线特征
Ophthalmology. 2005 Mar;112(3):376-85. doi: 10.1016/j.ophtha.2004.10.034.
9
A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial.原发性开角型青光眼口服抗氧化剂补充剂的两年随访:一项开放标签、随机、对照试验。
Acta Ophthalmol. 2015 Sep;93(6):546-54. doi: 10.1111/aos.12629. Epub 2014 Dec 28.
10
Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.Boston 1 型角膜移植术后青光眼的患病率、进展及其对视功能的影响。
Am J Ophthalmol. 2012 Feb;153(2):267-274.e1. doi: 10.1016/j.ajo.2011.07.022. Epub 2011 Oct 7.

引用本文的文献

1
TRPV4 controls circadian and pathological ocular hypertension.瞬时受体电位香草酸亚型4(TRPV4)控制昼夜节律性和病理性眼压升高。
J Physiol. 2025 Jul;603(14):4091-4111. doi: 10.1113/JP288706. Epub 2025 Jul 10.
2
TRPV4 subserves physiological and pathological elevations in intraocular pressure.瞬时受体电位香草酸亚型4(TRPV4)参与眼内压的生理和病理性升高。
Res Sq. 2024 Jul 12:rs.3.rs-4714050. doi: 10.21203/rs.3.rs-4714050/v1.
3
Is glaucoma an autoimmune disease?青光眼是自身免疫性疾病吗?
Clin Transl Immunology. 2020 Oct 6;9(10):e1180. doi: 10.1002/cti2.1180. eCollection 2020.
4
Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma.伴有闭角型青光眼患者的潜在不合理抗胆碱能药物处方。
Int Ophthalmol. 2020 Apr;40(4):803-809. doi: 10.1007/s10792-019-01241-2. Epub 2019 Dec 3.